Literature DB >> 21493031

Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program.

Amanda M Price1, Mark A Ilgen, Amy S B Bohnert.   

Abstract

Population-based data indicate that rates of nonmedical use of prescription opioids (POs) have increased dramatically over the past decade. However, data are lacking on nonmedical use of POs in individuals seeking treatment for substance use disorders. Patients (N = 351) seeking treatment from a residential drug and alcohol treatment program were assessed for nonmedical use of POs prior to treatment entry. Approximately 68% (65% men and 78% women) of patients reported at least some nonmedical PO use in the 30 days prior to treatment. Our results indicate that nonmedical PO use was more common in those with higher levels of depressive symptoms and pain intensity and in those with lower physical functioning. Treatment programs should consider actively screening participants for nonmedical PO use and consider how nonmedical use of pain medications might influence their treatment planning for patients. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493031     DOI: 10.1016/j.jsat.2011.02.003

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  16 in total

Review 1.  Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.

Authors:  Katie Witkiewitz; Kevin E Vowles
Journal:  Alcohol Clin Exp Res       Date:  2018-02-06       Impact factor: 3.455

2.  Risk for prescription opioid misuse among patients with a history of substance use disorder.

Authors:  Benjamin J Morasco; Dennis C Turk; Dennis M Donovan; Steven K Dobscha
Journal:  Drug Alcohol Depend       Date:  2012-07-18       Impact factor: 4.492

3.  Is employment status in adults over 25 years old associated with nonmedical prescription opioid and stimulant use?

Authors:  Alexander S Perlmutter; Sarah C Conner; Mirko Savone; June H Kim; Luis E Segura; Silvia S Martins
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-11-17       Impact factor: 4.328

4.  Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach.

Authors:  Perrine Roux; Patrizia M Carrieri; Julien Cohen; Isabelle Ravaux; Bruno Spire; Michael Gossop; Sandra D Comer
Journal:  Harm Reduct J       Date:  2011-11-28

5.  Associations among pain, non-medical prescription opioid use, and drug overdose history.

Authors:  Erin E Bonar; Mark A Ilgen; Maureen Walton; Amy S B Bohnert
Journal:  Am J Addict       Date:  2013-06-14

6.  Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use.

Authors:  Amy S B Bohnert; Anna Eisenberg; Lauren Whiteside; Amanda Price; Sean Esteban McCabe; Mark A Ilgen
Journal:  Addict Behav       Date:  2012-11-23       Impact factor: 3.913

7.  Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.

Authors:  Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-05-08       Impact factor: 3.829

Review 8.  Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain.

Authors:  Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Dan Haddad; Vijay Kodumudi; Niketh Kuruvilla; Alan David Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

9.  Opioid Misuse Trends in Treatment Seeking Populations: Revised Prescription Opioid Policy and Temporally Corresponding Changes.

Authors:  Lauren A Hoffman; Ben Lewis; Sara Jo Nixon
Journal:  Subst Use Misuse       Date:  2017-10-24       Impact factor: 2.164

10.  Alcohol, tobacco, and drug use among emergency department patients.

Authors:  Pilar M Sanjuan; Samara L Rice; Katie Witkiewitz; Raul N Mandler; Cameron Crandall; Michael P Bogenschutz
Journal:  Drug Alcohol Depend       Date:  2014-02-12       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.